“In the era of digitization, rather than therapeutics, data is pharma’s strongest asset.”
Christoph Schäfer, Managing Director
Health 4.0
Technology will drive patient engagement and enhance communication among all stakeholders. Sensors, data and algorithms predict optimal treatment plans and offer monitoring until recovery. Goal: Increased treatment efficacy and improved patient experience.
OUTCOME BASED PRICING
New pricing models will focus on outcome of medical treatments, rather than costs of drug classes. Imbursement is contingent on positive outcome of therapies.
Precision medicine
Drug products are tailored to patient classes and individuals. Interventions are focused on those who will benefit, preventing expenses and side effects for those who will not.
Diagnostics
Diagnostics enable physicians to assess expected treatment outcome ex-ante. They will be reimbursed by payers that benefit from reduced risk of non-performing treatments.
Patient Data
Electronic healthcare records, individual patient biometrics and real-time treatment records improve and monitor outcome of treatments. Blockchain is a key technology granting for data integrity, security and decentralized access rights.
R & D
Data will create further insights to disease pathways. Open innovation models including academia and early stage companies will increase R&D activity. Increased specialization is expected.
Clinical trials
Precision medicine and real-time monitoring will result in higher quality of clinical trial data. Patient recruitment is far more sophisticated and will lead to less drop outs.
Who we are
i.Logica of Switzerland is a consulting firm, specializing on digitzation and Health 4.0. Founded in 2006, we have developed a number of disruptive products and business models that are based on digital technology, including 3D-printing, connected devices and primary packaging.
We are operating within a global network of experts in IP, regulatory affairs, technology transfer and funding. We support all aspects of financial transactions prompted by your development: M&A transactions, selection of financial or strategic partners, non-dilutive funding, seed funding, assessment of business plans and many more. Ask us for a full list of services.
Bio
Christoph Schäfer holds an MBA of the University of Basel, Switzerland. He has been working in different roles in the Life Science industry since 1995, in sales, marketing, business development and innovation. He is a serial entrepreneur having developed a number of medical devices and drug products, starting from ideation, prototyping and lead generation to marketing authorization and sales.
Christoph enjoys mountain tours, climbing, skiing, sailing and martial arts. He is a member of the Rotary Club Liestal, alumni of Basel Economists and member of the Academic Society of Basel.
Contact
i.Logica GmbH is a limited liability corporation established under the laws of Canton of Obwalden, Switzerland, with its principal place of business at
i.Logica GmbH
Dorfstrasse 21
6390 Engelberg
We are dedicated to creating a personal business partnership. You will initiate it by calling +41 79 246 30 30.
UID CHE-112.745.685